Filed before 2025Filed 7 September 2021
Bakx Therapeutics, Inc. raised $20.3M
Bakx Therapeutics, Inc., a biotech company based in Bearsville, NY, raised $20.3M in a new equity round, according to a filing dated 7 September 2021.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 7 September 2021
- Round
- Equity round
- Amount sold
- $20.3M
- Offering size
- $34.3M
- Investors so far
- 3
- Based in
- Bearsville, NY
Investors on the board
- Ab Magnitude
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 64% of the 2,220 tracked raises with an amount filed in 2021, and than 49% of the 177 in biotech.
Bakx Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 7 Sep 2021 | New filing | $20.3M | This raise |
Other unannounced rounds
- NanosVet, Inc.$8.3M
- OhmNow, Inc$1.99M
- Thoughtform, Inc.$6.6M
- ProvenAir Technologies, Inc.$488K
- Whisper Aero Inc.$46.3M
- Gravitics, Inc.$17M
Seen it announced?
Send the link and the check will look at it.